Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection

被引：0
|
作者：
Zahra Bahari
Zohreh Jangravi
Hassan Ghoshooni
Mohammad Reza Afarinesh
Gholam Hossein Meftahi
机构：
[1] Baqiyatallah University of Medical Sciences,Department of Physiology and Medical Physics, Faculty of Medicine
[2] Baqiyatallah University of Medical Sciences,Neuroscience Research Center
[3] Baqiyatallah University of Medical Sciences,Department of Biochemistry, Faculty of Medicine
[4] Kerman University of Medical Sciences,Kerman Neuroscience Research Center, Institute of Neuropharmacology
来源：
Inflammation Research | 2021年 / 70卷
关键词：
Anti-rheumatoid agents; COVID-19; Cytokine storm; Immunotherapeutic drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：389 / 405
页数：16
相关论文
共 50 条
  • [31] Hyperinflammation Syndrome in COVID-19 Disease: Pathogenesis and Potential Immunomodulatory Agents
    Hidayat, Moulid
    Handayani, Diah
    Nurwidya, Fariz
    Andarini, Sita Laksmi
    TURKISH JOURNAL OF IMMUNOLOGY, 2021, 9 (01): : 1 - 11
  • [32] Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review
    Razmi, Mahdieh
    Hashemi, Farideh
    Gheytanchi, Elmira
    Manshadi, Masoumeh Dehghan
    Ghods, Roya
    Madjd, Zahra
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [33] Effective treatment of severe COVID-19 patients with tocilizumab
    Xu, Xiaoling
    Han, Mingfeng
    Li, Tiantian
    Sun, Wei
    Wang, Dongsheng
    Fu, Binqing
    Zhou, Yonggang
    Zheng, Xiaohu
    Yang, Yun
    Li, Xiuyong
    Zhang, Xiaohua
    Pan, Aijun
    Wei, Haiming
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (20) : 10970 - 10975
  • [34] COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement
    Wang, Charlie
    Rademaker, Marius
    Baker, Christopher
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2020, 61 (03) : 210 - 216
  • [35] Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review
    Jinghong Dai
    Yali Xiong
    Hui Li
    Yajun Qian
    Ying Xu
    Qingqing Xu
    Xin Yan
    Jian Tang
    Clinical Rheumatology, 2020, 39 : 2031 - 2037
  • [36] Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review
    Dai, Jinghong
    Xiong, Yali
    Li, Hui
    Qian, Yajun
    Xu, Ying
    Xu, Qingqing
    Yan, Xin
    Tang, Jian
    CLINICAL RHEUMATOLOGY, 2020, 39 (07) : 2031 - 2037
  • [37] COVID-19 infection in infant with severe CHD
    Pexton, Natalie
    Svenson, Amy
    Bhat, Deepti
    CARDIOLOGY IN THE YOUNG, 2021, 31 (10) : 1704 - 1705
  • [38] Immunomodulatory therapies for COVID-19
    Mathur, Poonam
    Kottilil, Shyamasundaran
    FRONTIERS IN MEDICINE, 2022, 9
  • [39] Analysis of 239 ordinary and severe cases of COVID-19: Clinical features and treatment
    Azizmohammadi, Susan
    Azizmohammadi, Sima
    Dahmardeh, Sarah
    Azargashb, Hossein
    Shokouh, Seyyed Javad Hosseini
    Mohajeri-Iravani, Mojgan
    Mobasher, Maziar
    Soleiman-Meigooni, Saeed
    Zabihi, Mahdi
    EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY, 2021, 31 (03)
  • [40] Severe scald injury in a patient with severe COVID-19 infection
    Stoegner, V-A
    Dieck, T.
    Vogt, P. M.
    Krezdorn, N.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2021, 62 : 522 - 526
12345